Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation AHA 2024

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Presenter: Oussama M. Wazni

November 16, 2024

Presentation EuroPCR 2023

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

Presenter: Xavier Freixa

May 17, 2023

Presentation TCT 2014

TCT 171: Avoidance of Major Bleeding with WATCHMAN Left Atrial Appendage Closure Compared with Long-term Oral Anticoagulation: A Pooled Analysis of Randomized Trials

Presenter: Saibal Kar, Bushra S Rana, Jai-Wun Park, Matthew J. Price

September 15, 2014

Presentation TCT 2014

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

Presenter: Saibal Kar

September 15, 2014

Presentation TCT 2014

No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications

Presenter: Jai-Wun Park

September 15, 2014

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Presentation TCT 2013

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Presenter: Michael Ezekowitz

October 27, 2013

Presentation TVT 2013

Who Is Really Contraindicated for Oral Anticoagulation Therapy? Are There Absolute Guidelines?

Presenter: Steven Goldberg

June 15, 2013

Presentation

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

Presenter: Vivek Y. Reddy

April 09, 2013

Presentation TCT 2012

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Presenter: Horst Sievert

October 23, 2012

Presentation

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Presenter: Vivek Y. Reddy

May 30, 2012

Advertisement

Randomized Comparison of Left Atrial Appendage Closure with Oral Anticoagulation after Catheter Ablation for Atrial Fibrillation

Low Dose Direct Oral Anticoagulation vs. DAPT after LAAO - ADALA Trial

TCT 171: Avoidance of Major Bleeding with WATCHMAN Left Atrial Appendage Closure Compared with Long-term Oral Anticoagulation: A Pooled Analysis of Randomized Trials

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Who Is Really Contraindicated for Oral Anticoagulation Therapy? Are There Absolute Guidelines?

LAA Closure with the Watchman Device in Patients with a Contraindication for Oral Anticoagulation

TCT-83. Watchman Left Atrial Appendage Closure in Atrial Fibrillation Patients with Contraindication to Oral Anticoagulation: the “Aspirin Plavix Registry” (ASAP)

Watchman LAA Closure in A-fib Patients with Contraindication to Oral Anticoagulation

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content